perflexane has been researched along with Cancer of Prostate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guo, L; Li, J; Liu, X; Meng, D; Shang, M; Shi, D; Sun, X; Zhao, Y; Zhou, X | 1 |
1 review(s) available for perflexane and Cancer of Prostate
| Article | Year |
|---|---|
Perflexane (AF0150, AFO 150, Imagent, Imavist).
Topics: Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Contrast Media; Coronary Circulation; Drug Approval; Endocardium; Fluorocarbons; Humans; Hydrocarbons, Brominated; Magnetic Resonance Angiography; Male; Microspheres; Prostatic Neoplasms | 2002 |
1 other study(ies) available for perflexane and Cancer of Prostate
| Article | Year |
|---|---|
Echogenic, Ultrasound-Sensitive Chitosan Nanodroplets for Spatiotemporally Controlled
Topics: Chitosan; Drug Carriers; Fluorocarbons; Humans; Intercellular Signaling Peptides and Proteins; Male; Nanoparticles; Plasmids; Prostatic Neoplasms; Transfection; Ultrasonic Waves | 2021 |